NeuroRx announced that Zyesami (aviptadil) met the primary endpoint of its Phase IIb/III trial, show
Read More
Earlier last week, Emergent BioSolutions’ production facility in Baltimore botched production for an
Read More
The European Medicines Agency (EMA)’s head of vaccines, Marco Cavaleri, believes there was a clear l
Read More
The current vaccines against COVID-19 that have been authorized, particularly the Moderna and Pfizer
Read More
The UK drugs regulator has said people aged under 30 should be offered an alternative to the AstraZe
Read More
Gilead’s $21 billion purchase of Immunomedics and its potential blockbuster Trodelvy continues to pa
Read More
UK artificial intelligence specialist Healx has begun a partnership with two medical charities that
Read More